Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Artesunate: From Viability to Cell Death
2026-09-07
Artesunate research is often judged by a single viability value, yet that value may combine growth arrest and cell killing. This article presents a response-phenotyping framework that connects Artesunate mechanism, assay design, and more defensible interpretation in cancer models.
-
SN-38 Disrupts FUBP1–FUSE DNA Binding
2026-09-05
The reference study identifies an additional activity of camptothecin and SN-38: inhibition of the interaction between the oncogenic transcriptional regulator FUBP1 and its single-stranded DNA target FUSE. By combining compound screening, AlphaScreen binding assays, and cellular gene-expression analysis, the authors connect topoisomerase I inhibitor pharmacology with transcriptional regulation in hepatocellular carcinoma.
-
Amitriptyline HCl: Practical Lab Workflow
2026-09-04
Amitriptyline HCl (SKU B2231) provides a characterized small molecule for controlled neurotransmitter receptor modulation studies, with defined reference activities, solubility, purity, and storage conditions. It is suitable for exploratory neuropharmacology research when assay-specific controls are used, but it should not be treated as evidence of therapeutic efficacy, receptor selectivity, or performance in a particular disease model.
-
GST-Driven Insecticide Resistance in M. usitatus
2026-09-04
The reference study identifies MuGSTs1 and GST-mediated antioxidant defense as important contributors to lambda-cyhalothrin resistance in Megalurothrips usitatus. Pharmacological GST inhibition with diethyl maleate reduced antioxidant capacity and markedly increased insecticide sensitivity, providing a mechanistic framework for resistance research and pest-management strategy design.
-
GSK343: From EZH2 Mechanism to Translation
2026-09-03
A thought-leadership guide to using GSK343 as a selective EZH2 inhibitor for mechanistic epigenetic cancer research, with a translational framework connecting PRC2 biology, H3K27me3 control, and emerging APEX2–TERT findings.
-
NP-40 Lysis Buffer for Neuroimmune Assays
2026-09-03
NP-40 Lysis Buffer can preserve native protein assemblies and phosphorylation states needed to interpret neuroimmune signaling. This guide develops an assay-selection framework linking extraction chemistry to FPR2/ALX, SYK-AKT, microglial, and NK-cell experiments.
-
7-Ethyl-10-hydroxycamptothecin Workflows
2026-09-02
Build more informative cancer assays with 7-Ethyl-10-hydroxycamptothecin, combining topoisomerase I inhibition, cell-cycle profiling, apoptosis measurements, and FUBP1–FUSE binding studies. This practical guide emphasizes fresh DMSO handling, time-resolved dosing, metastatic colon cancer models, and troubleshooting for reproducible advanced colon cancer research.
-
DAPI Nuclear Stain Solution: Practical Protocol
2026-09-02
DAPI (4',6-Diamidino-2-Phenylindole) Nuclear Stain Solution, SKU K2402, provides a pre-diluted fluorescent DNA binding dye for nuclear visualization and endpoint assessment of membrane-compromised cells. It is suited to fixed-cell fluorescence microscopy and selected flow cytometry workflows, but its weak cell permeability limits routine staining of intact live cells.
-
Obeticholic Acid: Designing Better FXR Assays
2026-09-01
Obeticholic Acid is a selective FXR agonist for mechanistic studies of bile acid homeostasis, cholestasis, and liver fibrosis. This article presents an assay-centered framework that connects FXR gene regulation with the Notch and NK-cell findings reported in recent fibrosis research without conflating distinct mechanisms.
-
Central Control of Opioid Mechanical Hypersensitivity
2026-08-31
Yin et al. identify a brain-to-spinal opioid circuit that links repeated morphine exposure to mechanical hypersensitivity and analgesic tolerance in mice. The study separates mechanical pain adaptations from thermal effects and provides a circuit-level framework for opioid receptor signaling research and chronic pain research.
-
Sodium-Driven Mitochondrial Failure in NECSO
2026-08-31
Qiao and colleagues show that TRPM4-mediated sodium influx drives NECSO by disrupting mitochondrial ion handling, oxidative phosphorylation, and the TCA cycle rather than acting only through plasma-membrane ion imbalance. The work establishes a mechanistic connection between sodium overload, ATP failure, Na/K-ATPase collapse, cellular swelling, and necrotic lysis, providing a framework for targeted mitochondrial function analysis.
-
Human iPSC Sensory Neurons Model HSV-1 Latency
2026-08-30
Oh et al. developed and validated a scalable human iPSC-derived sensory neuron system that supports HSV-1 latency and experimentally induced reactivation. The model combines neuronal function with virological and chromatin-based latency criteria, providing a more human-relevant platform for studying neuron-intrinsic mechanisms and antiviral strategies.
-
Toremifene in Breast Cancer: 20 Years of Evidence
2026-08-29
This review examines two decades of clinical and pharmacologic evidence for toremifene, a selective estrogen receptor modulator used in estrogen receptor-positive breast cancer. Its main contribution is to place efficacy, metabolism, tissue-selective effects, and safety in a personalized-treatment framework rather than presenting toremifene as uniformly superior to tamoxifen or aromatase inhibitors.
-
7-Ethyl-10-hydroxycamptothecin in Translation
2026-08-28
A translational framework for using 7-Ethyl-10-hydroxycamptothecin (SN-38) to connect topoisomerase I inhibition, replication-associated damage, apoptosis, cell-cycle control, and FUBP1 biology in advanced colon cancer research.
-
Artesunate Workflows for Cancer Research
2026-08-28
Artesunate enables a more informative cancer-response workflow by separating growth suppression from actual cell killing. This guide translates its ferroptosis- and AKT/mTOR-relevant biology into practical dosing, time-course, assay-selection, and troubleshooting strategies for reproducible in vitro studies.